• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经部分容积平均效应校正后,通过正电子发射断层扫描测量的阿尔茨海默病区域代谢减低。

Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging.

作者信息

Meltzer C C, Zubieta J K, Brandt J, Tune L E, Mayberg H S, Frost J J

机构信息

Department of Radiology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.

出版信息

Neurology. 1996 Aug;47(2):454-61. doi: 10.1212/wnl.47.2.454.

DOI:10.1212/wnl.47.2.454
PMID:8757020
Abstract

Measurements of cerebral metabolism in patients with Alzheimer's disease (AD) using PET are artifactually depressed due to partial volume averaging of brain tissue activity with enlarged CSF spaces. To investigate the effects of correction for the expansion of CSF spaces on regional metabolic measures, as well as the correlations between neuropsychological test results and resting cerebral metabolism before and after partial volume correction, we applied an MRI-based method of partial volume correction to 18F-fluorodeoxyglucose (FDG)-PET data from eight patients diagnosed with probable AD and ten healthy elderly individuals. Before correction, the AD group had significantly lower cortex-to-cerebellum ratios in the posterior temporal, parietal, and frontal lobes in comparison to the control subjects. Partial volume correction of PET data resulted in 19 to 49% increases in regional activity in the AD group and 16 to 38% increases in the control group. The patients' persistence of significant hypometabolism in the frontal, posterior temporal, and parietal regions after partial volume correction suggests that a true reduction in regional cerebral glucose metabolism occurs in AD, even though its magnitude is a result of both metabolic reductions and the effects of atrophy. Partial volume correction of PET data in the AD group had a significant impact on the correlations between regional glucose metabolism and neuropsychological performance. These findings suggest that accounting for differential extent and distribution of cerebral atrophy in patients with AD and in healthy individuals may potentially improve our ability to interpret specific cognitive dysfunction in the context of the functional imaging data.

摘要

由于脑脊液间隙扩大导致脑组织活动的部分容积平均效应,使用正电子发射断层扫描(PET)对阿尔茨海默病(AD)患者进行脑代谢测量时会出现人为降低的情况。为了研究脑脊液间隙扩大校正对区域代谢测量的影响,以及部分容积校正前后神经心理学测试结果与静息脑代谢之间的相关性,我们对8例诊断为可能患有AD的患者和10名健康老年人的18F-氟脱氧葡萄糖(FDG)-PET数据应用了基于磁共振成像(MRI)的部分容积校正方法。校正前,与对照组相比,AD组颞叶后部、顶叶和额叶的皮质与小脑比值显著降低。PET数据的部分容积校正使AD组的区域活性增加了19%至49%,对照组增加了16%至38%。部分容积校正后,患者额叶、颞叶后部和顶叶区域仍存在显著的代谢减退,这表明AD患者区域脑葡萄糖代谢确实降低,尽管其程度是代谢降低和萎缩效应共同作用的结果。AD组PET数据的部分容积校正对区域葡萄糖代谢与神经心理学表现之间的相关性有显著影响。这些发现表明,考虑AD患者和健康个体脑萎缩的不同程度和分布,可能会提高我们在功能成像数据背景下解释特定认知功能障碍的能力。

相似文献

1
Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging.经部分容积平均效应校正后,通过正电子发射断层扫描测量的阿尔茨海默病区域代谢减低。
Neurology. 1996 Aug;47(2):454-61. doi: 10.1212/wnl.47.2.454.
2
Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease.区域葡萄糖代谢异常并非阿尔茨海默病中萎缩的结果。
Neurology. 1998 Jun;50(6):1585-93. doi: 10.1212/wnl.50.6.1585.
3
Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter.阿尔茨海默病中有无严重白质异常情况下正电子发射断层扫描、认知及脑容量的比较
J Neurol Neurosurg Psychiatry. 1996 Feb;60(2):158-67. doi: 10.1136/jnnp.60.2.158.
4
Positron emission tomography metabolic data corrected for cortical atrophy using magnetic resonance imaging.使用磁共振成像对皮质萎缩进行校正后的正电子发射断层扫描代谢数据。
Alzheimer Dis Assoc Disord. 1996 Fall;10(3):141-70. doi: 10.1097/00002093-199601030-00005.
5
Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.痴呆症患者脑代谢衰退的纵向PET评估:阿尔茨海默病治疗研究中的一种潜在结局指标
Am J Psychiatry. 2002 May;159(5):738-45. doi: 10.1176/appi.ajp.159.5.738.
6
The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease.脑萎缩对阿尔茨海默病视觉变异型脑代谢减低的影响。
Arch Neurol. 2001 Mar;58(3):480-6. doi: 10.1001/archneur.58.3.480.
7
A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.一项针对认知健康的老年人、轻度认知障碍和早期阿尔茨海默病患者大脑葡萄糖和酮体代谢的横断面比较。
Exp Gerontol. 2018 Jul 1;107:18-26. doi: 10.1016/j.exger.2017.07.004. Epub 2017 Jul 12.
8
Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease.阿尔茨海默病中灰质代谢减退与萎缩之间基于体素的直接比较。
Brain. 2008 Jan;131(Pt 1):60-71. doi: 10.1093/brain/awm288. Epub 2007 Dec 5.
9
Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.阿尔茨海默病中脑脊液乳酸水平与默认模式网络内脑[18F]氟代脱氧葡萄糖正电子发射断层扫描低代谢
Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):2040-9. doi: 10.1007/s00259-016-3417-2. Epub 2016 May 25.
10
CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease.阿尔茨海默病中脑脊液总tau蛋白和磷酸化tau蛋白、局部葡萄糖代谢与痴呆严重程度
Eur J Neurol. 2008 Nov;15(11):1155-62. doi: 10.1111/j.1468-1331.2008.02274.x. Epub 2008 Sep 18.

引用本文的文献

1
Cognitive impairment in chronic kidney disease: role of brain imaging, functional imaging, electroencephalography, cerebrospinal fluid biomarkers and sensors.慢性肾脏病中的认知障碍:脑成像、功能成像、脑电图、脑脊液生物标志物及传感器的作用
Nephrol Dial Transplant. 2025 Mar 13;40(Supplement_2):ii18-ii27. doi: 10.1093/ndt/gfae256.
2
Assessing the metabolism of the olfactory circuit by use of F-FDG PET-CT imaging in patients suspected of suffering from Alzheimer's disease or frontotemporal dementia.使用 F-FDG PET-CT 成像评估疑似阿尔茨海默病或额颞叶痴呆患者的嗅觉回路代谢。
Alzheimers Res Ther. 2024 Oct 29;16(1):241. doi: 10.1186/s13195-024-01604-7.
3
Role of glia in delirium: proposed mechanisms and translational implications.
神经胶质细胞在谵妄中的作用:提出的机制及转化意义。
Mol Psychiatry. 2025 Mar;30(3):1138-1147. doi: 10.1038/s41380-024-02801-4. Epub 2024 Oct 27.
4
Common molecular and pathophysiological underpinnings of delirium and Alzheimer's disease: molecular signatures and therapeutic indications.谵妄和阿尔茨海默病的常见分子和病理生理学基础:分子特征和治疗指征。
BMC Geriatr. 2024 Aug 29;24(1):716. doi: 10.1186/s12877-024-05289-3.
5
F-FDG-PET correlates of aging and disease course in ALS as revealed by distinct PVC approaches.通过不同的体素容积校正(PVC)方法揭示的肌萎缩侧索硬化症(ALS)中衰老与疾病进程的F-FDG-PET相关性。
Eur J Radiol Open. 2022 Jan 13;9:100394. doi: 10.1016/j.ejro.2022.100394. eCollection 2022.
6
Treatment of Delirium During Critical Illness.治疗危重病患者的意识障碍。
Annu Rev Med. 2022 Jan 27;73:407-421. doi: 10.1146/annurev-med-042220-013015. Epub 2021 Nov 9.
7
Bridging Scales in Alzheimer's Disease: Biological Framework for Brain Simulation With The Virtual Brain.阿尔茨海默病中的跨尺度关联:利用虚拟大脑进行脑模拟的生物学框架
Front Neuroinform. 2021 Apr 1;15:630172. doi: 10.3389/fninf.2021.630172. eCollection 2021.
8
Alzheimer's disease alters oligodendrocytic glycolytic and ketolytic gene expression.阿尔茨海默病改变少突胶质细胞糖解和酮解基因表达。
Alzheimers Dement. 2021 Sep;17(9):1474-1486. doi: 10.1002/alz.12310. Epub 2021 Mar 2.
9
Delirium.谵妄。
Nat Rev Dis Primers. 2020 Nov 12;6(1):90. doi: 10.1038/s41572-020-00223-4.
10
Alzheimer's Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials.唐氏综合征相关阿尔茨海默病:药物预防试验的设计和实施进展。
CNS Drugs. 2020 Aug;34(8):785-794. doi: 10.1007/s40263-020-00740-6.